Sendai Virus Vector: Advantages and Applications

Author:   Yoshiyuki Nagai
Publisher:   Springer Verlag, Japan
Edition:   Softcover reprint of the original 1st ed. 2013
ISBN:  

9784431561163


Pages:   210
Publication Date:   23 August 2016
Format:   Paperback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $448.77 Quantity:  
Add to Cart

Share |

Sendai Virus Vector: Advantages and Applications


Add your own review!

Overview

Full Product Details

Author:   Yoshiyuki Nagai
Publisher:   Springer Verlag, Japan
Imprint:   Springer Verlag, Japan
Edition:   Softcover reprint of the original 1st ed. 2013
Dimensions:   Width: 15.50cm , Height: 1.20cm , Length: 23.50cm
Weight:   0.472kg
ISBN:  

9784431561163


ISBN 10:   4431561161
Pages:   210
Publication Date:   23 August 2016
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

1. Reverse genetics of Mononegavirales: the rabies virus paradigm Karl-Klaus Conzelmann.-   2. Sendai virus biology and engineering leading up to the development of a novel class of expression vector Yoshiyuki Nagai and Atsushi Kato.-   3. Concept and technology underlying Sendai virus (SeV) vector development Akihiro Iida and Makoto Inoue.-   4. Roadmap for development of a replication-deficient Sendai virus vaccine vector (provisional) Marian Wiegand and Wolfgang Neubert.-   5. Development of vaccines using SeV vectors against AIDS and other infectious diseases Sayuri Seki and Tetsuro Matano.-   6. BioKnife, a modified Sendai virus, to resect malignant tumors Yoshikazu Yonemitsu, Yasuji Ueda and Mamoru Hasegawa.-   7. Induction of human pluripotent stem cells by the Sendai virus vector:Establishment of a highly efficient and foot-print free system Noemi Fusaki and Hiroshi Ban.-   8. Gene therapy for peripheral arterial disease using Sendai virus vector: From preclinical Studies to the phase I/IIa clinical trial Yoshikazu Yonemitsu, Takuya Matsumoto and Yoshihiko Maehara.

Reviews

Author Information

Editor Yoshiyuki Nagai, M.D. Ph.D. Director, RIKEN Center of Research Network for Infectious Diseases, Japan

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List